Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
Philipp Spatz, Sophie A. M. Steinmüller, Anna Tutov, Eleonora Poeta, Axelle Morilleau, Allison Carles, Marie H. Deventer, Julian Hofmann, Christophe P. Stove, Barbara Monti, Tangui Maurice, Michael Decker
Abstract
R activation in vivo.
Topics & Concepts
ChemistryButyrylcholinesteraseNeuroprotectionCannabinoidCannabinoid receptorPharmacologyCannabinoid receptor type 2RadioligandAgonistIn vivoReceptorMicrogliaNeurodegenerationBiochemistryAcetylcholinesteraseInternal medicineInflammationBiologyImmunologyEnzymeMedicineAchéDiseaseBiotechnologyCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology ResearchCannabis and Cannabinoid Research